Felix Kratz - Publications

Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.

Journal: International journal of molecular sciences

Published: December 23, 2020

Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors.

Journal: Nuclear medicine and molecular imaging

Published: December 13, 2018

Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 23, 2018

Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.

Journal: Journal of drug targeting

Published: July 25, 2017

The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 15, 2016

Engineered drug-protein nanoparticle complexes for folate receptor targeting.

Journal: Biochemical engineering journal

Published: July 15, 2014

WITHDRAWN: A clinical update of using albumin as a drug vehicle - A commentary.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 28, 2014

A clinical update of using albumin as a drug vehicle - a commentary.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 28, 2014

A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 20, 2013

Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix.

Journal: Journal of medicinal chemistry

Published: August 14, 2012

Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.

Journal: International journal of pharmaceutics

Published: June 30, 2012

Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.

Journal: Molecular cancer therapeutics

Published: April 26, 2012